Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer

被引：1

作者：

Yamaguchi, Teppei ^{[1
]}

Hida, Toyoaki ^{[1
]}

机构：

[1] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan

来源：

TRANSLATIONAL CANCER RESEARCH | 2019年 / 8卷 / 08期

关键词：

PHASE-III; MAINTENANCE BEVACIZUMAB; CHEMOTHERAPY; COMBINATION; NIVOLUMAB; DOCETAXEL; EFFICACY; THERAPY; SAFETY;

D O I：

10.21037/tcr.2019.12.57

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E11 / E14

页数：4

共 50 条

[41] An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer
Afzal, Muhammad Zubair
Dragnev, Konstantin H.
Shirai, Keisuke
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
[42] Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab plus Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer
Hou, Junjie
Mi, Xuguang
Liu, Ning
Yang, Ying
Qi, Zhaoxue
Li, Xiaonan
Lu, Xiaodan
Jiang, Xianzhuo
Yu, Yingying
Zhou, Ying
Ni, Zhiqiang
Fang, Yanqiu
Jin, Ningyi
JOURNAL OF ONCOLOGY, 2022, 2022
[43] nab-Paclitaxel for the Treatment of Advanced Squamous Non-Small-Cell Lung Cancer: A Comprehensive Update
Simon, George R.
CLINICAL LUNG CANCER, 2014, 15 (06) : 391 - 397
[44] An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
Chang, John Wen-Cheng
Thongprasert, Sumitra
Wright, Elaine
Tsang, Kenneth
Kim, Heung Tae
Ahn, Myung-Ju
Kim, Joo-Hang
Kang, Jin Hyoung
Kim, Sang-We
Walzer, Stefan
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 13 - 21
[45] The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients
Tanaka, Miho
Hattori, Yoshihiro
Ishii, Tatsuya
Tohnai, Rie
Itoh, Shoichi
Kawa, Yoshitaka
Kono, Yuko
Urata, Yoshiko
Satouchi, Miyako
RESPIRATORY INVESTIGATION, 2020, 58 (04) : 269 - 274
[46] nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis
Langer, Corey J.
Gajra, Ajeet
Gridelli, Cesare
Konduri, Kartik
Morgensztern, Daniel
Spigel, David
Talbot, Denis
Thomas, Michael
Weiss, Jared
Pilot, Richard
Bhore, Rafia
Wolfsteiner, Marianne
Ong, Teng Jin
Socinski, Mark
FRONTIERS IN ONCOLOGY, 2021, 10
[47] Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer
Nakashima, Kazuhisa
Akamatsu, Hiroaki
Murakami, Haruyasu
Niwa, Takashi
Iwamoto, Yasuo
Ozawa, Yuichi
Yokoyama, Toshihide
Shoda, Hiroyasu
Yamamoto, Nobuyuki
Yoshioka, Hiroshige
Masuda, Ken
Naito, Tateaki
Mori, Keita
Takahashi, Toshiaki
ANTICANCER RESEARCH, 2019, 39 (03) : 1463 - 1468
[48] An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Pemetrexed-Carboplatin versus (Weekly) Paclitaxel-Carboplatin as First-Line Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Yadav, Ajay
Malik, Prabhat Singh
Khurana, Sachin
Jain, Deepali
Vishnubhatla, Sreenivas
Yadav, Mukesh
Pathy, Sushmita
Mohan, Anant
Kumar, Lalit
ONCOLOGY, 2021, 99 (06) : 389 - 396
[49] Carboplatin plus Weekly Paclitaxel Treatment in Non-small Cell Lung Cancer Patients with Interstitial Lung Disease
Shukuya, T.
Ishiwata, T.
Hara, M.
Muraki, K.
Shibayama, R.
Koyama, R.
Takahashi, K.
ANTICANCER RESEARCH, 2010, 30 (10) : 4357 - 4361
[50] Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
Kaya, Ali Osman
Buyukberber, Suleyman
Dane, Faysal
Isikdogan, Abdurrahman
Ustaalioglu, Basak Oven
Coskun, Ugur
Yumuk, Perran Fulden
Dogu, Gamze Gokoz
Ozdemir, Nuriye Yildirim
Sevinc, Alper
Gumus, Mahmut
Ozkan, Metin
Yildiz, Ramazan
Ozturk, Banu
Yaman, Emel
Benekli, Mustafa
TUMORI JOURNAL, 2010, 96 (03): : 400 - 404

← 1 2 3 4 5 →